| Prev Close | 108.33 |
| Open | 108.34 |
| Day Low/High | 107.39 / 112.39 |
| 52 Wk Low/High | 62.88 / 109.51 |
| Volume | 1.94M |
| Avg Volume | 1.74M |
BioMarin Pharmaceutical Inc. (BMRN)
111.21
2.88
2.66
NASDAQ : Health Technology
| Exchange | NASDAQ |
| Shares Outstanding | 180.84M |
| Market Cap | 19.42B |
| EPS | -0.10 |
| P/E Ratio | 170.46 |
| Div & Yield | N.A. (N.A) |
Biotech, Chips Stand Their Ground
You can't help but feel better about both groups.
The 7 Pillars of Healthcare Strength
Here are healthcare stocks of all shares and sizes with strong charts.
Biotech Stocks at a Crossroad
Own them, or take something off the table?
Remarkable Biotech Runs Continue
A Fed-related dip may be your only hope to get in lower.
What Is Wrong With You People?
These companies are doing great -- take some profits!
Market Rewards Biotech Latecomers
It shouldn't be possible, but it never seems too late to get in.
That's Just What's Supposed to Happen
Stocks that stabilized yesterday were terrific today.
The Biotechs Are Feeling Better
Sector could regain its leadership role.
The Biotechs Are Back
Watch this leadership group that's been lagging.
8 Signs the Market Is Remarkably Healthy
These are surefire indications of a bountiful tape.
Markets Lack Liquidity
Liquidity is crucial to maintaining trust in the system.
Cramer: Oil-and-Gas vs. Everything Else
Reams of stocks make sense on a pullback. And what looks bad? Anything even remotely connected to oil and gas.
'Top Fishing' Is the Name of the Game
Stocks, like sports, are unfair sometimes. This is one of those times.
Cramer: A Dozen Sectors to Snap Up
As 2014 winds down, you could almost throw darts at these standout groups -- but here are my own picks.
Resistance Is Futile
Here are three stock that have returned to former breakout levels.
Time to Do Some Gardening
Use the oversold bounces for trimming, cutting or hedging positions.
The Trader Daily
The focus is on all things momentum.
The Trader Daily
For Es, I believe the odds will remain in the bulls' favor.
The Trader Daily
No reason to be bearish on the SPY.
The Trader Daily
Don't sweat Wednesday's dip in the SPY.
The Trader Daily
The $193 level on the SPY will be key today.
The Trader Daily
Thursday's SPY trade plan will involve fading the edges,
A Tale of Diversification
BioMarin and Goldcorp couldn't be more different -- and similar.
Get Used to the New Market Reality
Algos think faster and react faster than humans can.
A Blueprint for Highflier Stability
Cautionary tales that the IPO window might be closing at last.
Wait for the All-Clear
In other words, wait for the downgrades.
